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Abstract 
The most frequently used method to demonstrate testosterone 
abuse is the determination of the testosterone and epitestosterone 
concentration ratio (T/E ratio) in urine. Nevertheless, it is known 
that factors other than testosterone administration may increase 
the T/E ralio. In the last years, the determination of the carbon 
isotope ratio has proven to be the most promising method to help 
discriminate between naturally elevated T/E ratios and those 
reflecting T use. In this paper, an excretion study following 
oral administration of 40 mg testosterone undecanoate initially 
and 13 h later is presented. Four testosterone metabolites 
(androsterone, etiocholanolone, 5o~-androstanediol, an  
5[~-androstanediol) together with an endogenous reference 
(5[3-pregnanediol) were extracted from the urines and the 
~t3C/12C ratio of each compound was analyzed by gas 
chromatography-combustion-isotope ratio mass spectrometry. 
The results show similar maximum 613C-value variations (parts 
per thousand difference of 813C/12C ratio from the isotope ratio 
standard) for the T metabolites and concomitant changes of the 
T/E ratios after administration of the first and the second dose 
of T. Whereas the T/E ratios as well as the androsterone, 
etiocholanolone and 5u.-androstanediol 813C-values returned to 
the baseline 15 h after the second T administration, a decrease of 
the 5~-androstanediol ~-values could be detected for over 40 h. 
This suggests that measurements of 5~-androstanediol 8-values 
allow lhe detection of a testosterone ingestion ver a longer 
post-administration period than other T metabolites 813C-values 
or than the usual T/E ratio approach. 
Introduction 
The detection of doping with testosterone is mainly based on 
the concentration measurement of the testosterone (T) to 
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epitestosterone (E) ratio (T/E ratio). If this T/E ratio is greater 
than 6 in the urine of a competitor, it is mandatory that addi- 
tional investigations should be conducted. Isotope ratio mass 
spectrometry (IRMS) may be used in this context as an addi- 
tional analysis to help in deciding whether an elevated T/E 
ratio can be explained by a misuse of testosterone (1-4) or 
testosterone precursors (4,5). Indeed, it is known that other fac- 
tors than testosterone administration may lead to T/E ratio 
exceeding 6 (6,7). 
IRMS allows measurements of slight differences in the carbon 
isotope ratio (13C/12C) of the exogenous and endogenous testos- 
terone. Synthetic testosterone is produced from precursors de- 
rived from plants with low 13C content, whereas the 13C and 12C 
content in the natural endogenous form depends on the iso- 
topic carbon composition of the food diet and is influenced by 
additional effects of human biological processing (8). Such dif- 
ferentiation between synthetic and endogenous origins has 
also been reported for other hormones such as epitestosterone 
(9), nandrolone (10), and corticosteroids (11). 
Very few time profile IRMS studies with the chronological de- 
termination ofT/E ratio after oral testosterone administration 
are reported in the literature (2,3,12). Chronological measure- 
ment of the carbon isotopic ratio of T metabolites was able to 
detect T administration i cases in which the T/E ratio re- 
mained below 6 (2). It must be noted that in this latter study the 
five volunteers were of Chinese ethnicity, and therefore, the 
cutoff limit of a T/E ratio of 6 that is suited for the caucasian 
race is questionable when used on a Chinese ubject population. 
It is also worth mentioning that the excretion studies on two 
caucasian volunteers after one oral ingestion ofT undecanoate 
(3). These xcretion studies report he detection of exogenous 
T by gas chromatography-combustion-isotope rati  mass pec- 
trometry (GC-C-IRMS) after the T/E ratio had returned to 
below 6. The determination f exogenous T with GC-C-IRMS 
was possible for more than twice as long as with application of 
T/E ratio limits. 
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This paper describes the time courses of isotopic ratio values 
in urine of androsterone (Andro), etiocholanolone (Etio), 5(x-
androstanediol (5aA), 513-androstanediol (513A), and the en- 
dogenous reference 5[~-pregnanediol (513P) in the frame of an 
excretion study following oral ingestion of testosterone ini- 
tially and 13 h later by a healthy, male, caucasian volunteer 
(Figure 1). The profile of the T/E ratio is also compared with the 
results obtained by IRMS. These excretion studies are funda- 
mental in understanding how the time profile ofIRMS values 
is affected after multiple oral ingestions of testosterone. To our 
knowledge, there is no report of chronological application of the 
isotope ratio technology and the T/E ratio to monitor an ex- 
cretion study with multiple oral testosterone ingestions. 
Experimental 
Chemicals 
All solvents and reagents of analytical grade purity were pur- 
chased from Fluka (Buchs, Switzerland). 5c~-Androstan-3[3-ol 
acetate, 5~-androstane-3(~,1713-diol, 513-androstane-3(~,17[~- 
diol, 5[3-pregnane-3(x,20c~-diol, etiocholanolone, and andros- 
terone with a purity of at least 99.5% were obtained either 
from Steraloids Inc. (Newport, RI) orSigma Chemical Co. (St. 
Louis, MO). Bakerbond spe TM 500-rag or 1000-mg octadecyl C18 
disposable extraction columns were obtained from J.T. Baker 
(Phillipsburg, N J). ~-Glucuronidase fromEscherichia coli in a 
50% glycerol solution (pH 6.5, 140 U/mL at 37~ was supplied 
by Roche Diagnostics GmbH (Mannheim, Germany). The ref- 
erence carbon dioxide gas was purchased from Carbagaz (Dom- 
didier, Switzerland). The mixture of three alkanes, C15 
(n-pentadecane), C20(n-eicosane), and C25 (n-pentacosane), 
was supplied by Chiron AS (Trondheim, Norway). 
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Figure 1. Metabolic pathways of testosterone. 
Dosage and collection of urine samples 
A 40-mg testosterone undecanoate capsule (Panteston | 
Organon SA, France) were self-administered orally initially and 
13 h later by a healthy, male, caucasian volunteer. Baseline 
urine samples were obtained before initial administration, and 
39 subsequent spot urine samples were collected over a period 
of 100 h after the first capsule administration. Reference urine 
samples were collected from 40 caucasian male subjects. In 
this excretion study, the spot urine with the T/E ratio of 36 at 
t = 2.3 h was selected to be the positive quality control u ine 
(QC-pos). The negative quality control urine (QC-neg) was ob- 
tained from a healthy subject. Each urine was aliquoted into 15- 
mL cryogenic tubes and stored without additives at-20~ until 
analysis. 
Sample preparation 
The urine sample (10 mL) was centrifuged inglass tubes at
2500 rpm for 5 min and was applied onto a C18 column (500 
rag). The conjugated steroids were eluted with methanol (8 
mL) and the eluate vaporated to dryness. Tohydrolyze the con- 
jugated steroids, the residue was dissolved in 1 mL of 0.2M 
phosphate buffer (pH 7.0) and 50 pL of [3-glucuronidase was 
added as supplied. After incubation at 50~ during I h (or at 
37~ overnight) in a thermostated water bath, the deconjugated 
steroids were extracted on C18 column (500 rag) by washing 
with 6 mL acetonitrile/H~O (20:80, v/v) and subsequently b 6 
mL acetonitrile/H20 (35:65, v/v) and finally eluted with 12 mL 
acetonitrile. The eluate was vaporated to dryness under a ni- 
trogen stream (Turbo Vap LV evaporator, Zymark, Hopkinton, 
MA), and then the residue was dried over phosphorus pen- 
toxide for 20 min. Acetylation f the extract was carried out in 
50 pL of pyridine and 50 pL of acetic anhydride at 60~ for 1 h 
incubation. The reaction medium was evaporated to dryness 
and subsequently theresidue was redissolved in 3 mL of ace- 
tonitrile/H20 (50:50, v/v). The solution was applied onto a C18 
column (1000 rag). The fraction F1 containing androsterone 
and etiocholanolone was obtained by elution with 15 mL ace- 
tonitrile/H20 (75:25, v/v) after washing with 12 mL of acetoni- 
trile/H20 (50:50, v/v). Finally, the fraction F2 with the 
androstandiols and thepregnanediol was obtained by eluting 
with 12 mL of acetonitrile. The derivatized steroids of frac- 
tions F1 and F2 were spiked with 40 I~L and 10 I~L of an internal 
standard (IS, 5(~-androstan-3[3-ol acetate, 0.20 mg/mL in 
methanol), respectively. Then both fractions F1 and F2were 
evaporated to dryness and finally dissolved in500 pL and 40 pL 
of cyclohexane, r spectively. 
GC-C-IRMS analysis 
The carbon isotope measurements were performed on a 
Delta Plus IRMS system (Thermo Finnigan MAT,Bremen, Ger- 
many) coupled to an Agilent 6890A GC (HP Analytical Division, 
Waldbronn, Germany) via a Finnigan GC Combustion III in- 
terface (Thermo Finnigan MAT,Bremen, Germany) and a CTC 
Analytics CombiPal autosampler (CTC Analytics AG, Zwingen, 
Switzerland). Chromatographic separations were achieved on 
an HP cross-linked 50% phenylmethylsiloxane fused silica cap- 
illary column (J&W Scientific, 30 m x 0.25-ram i.d., 0.15-pro 
film thickness). The injector temperature was set to 280~ 
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The combustion and reduction oven temperatures were set to 
940~ and 600~ respectively. Reference carbon dioxide gas 
pulses (20-s durations) were introduced at four different times 
during the course of the chromatographic separation. For the 
calibration of the reference gas with the alkane mixture of 
known 813C-values, the oven temperature was increased from 
80~ (1 rain) to 270~ (7.0 min) at 15~ For the analysis 
of the androsterone and etiocholanolone acetates (fraction F1), 
the oven temperature was increased from 80~ (1 min) to 
270~ (8.3 min) at 15~ then to 300~ at 35~ and 
maintained atthe final temperature for 3 rain. For the analysis 
of the fraction F2 containing the androstandiols and the preg- 
nanediol acetates, theoven temperature was increased from 
80~ (1 rain) to 270~ (11.5 min) at 15~ then to 300~ 
at 35~ and maintained at the final temperature for 
3 min. The volume of injection was 1-2 pL, depending on the 
estimated concentrations of the compounds of interest as eval- 
uated in the frame of the T/E ratio determination. The extracts 
were injected twice in the splitless mode, and the replicate 
measurements were averaged. 
The symbol 8 is the standard notation for expressing carbon 
isotope ratios. It is defined as parts per thousand eviation of 
isotopic compositions from that of Pee Dee Belemnite (PDB), 
and is calculated according to: 
813C/%_ (13C/12C)sample - (13C/12C)standard 
(13C/12C)standard 
Negative shifts ofthe 813C-value due to the formation of an 
acetate were corrected as follows: 
DOH = DoAc + 2m (D~ - DAc) 
n 
Where Dou is (31:lC-value for the underivatized steroids, DOA c 
is the 81:~C-value for the acetylated steroids, DAc is the 813C - 
value for the acetylating reagent, n is the number of carbon 
atom in a molecule, and m is the number of hydroxyl groups to 
be acetylated. 
All subsequent 813C-values have been corrected for this neg- 
ative shift. The DAC value of our acetylating reagent was deter- 
mined to be -48.8%o according to a published procedure (13). 
Determination of steroid concentration and T/E ratio 
Urinary testosterone and epitestosterone w re quantified in 
all the samples and the concentration f the steroids of in- 
terest were quantified according to the method of Nolteernsting 
et al (14). 
Results and Discussion 
Isotope measurements, accuracy, and reproducibility 
of the method 
The reference carbon dioxide gas, which is pulsed several 
times during the course of the chromatographic separation, is
calibrated by a mixture of three alkanes, CI5 (n-pentadecane), 
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C20 (n-eicosane), and C25 (n-pentacosane), from Chiron AS 
with 813C-values of-30.22, -33.06, and-28.21%o, respectively. 
The internal standard (5or acetate) was mea- 
sured together with this alkane mixture and the 813C value 
was -31.9%o (n = 50,SD = 0.2%o). 
The extraction method allows the separation of androsterone 
(Andro) and etiocholanolone (Etio) acetates from the 5cr 
drostanediol (5(zA), 5[3-androstanediol (5~A), and pregnane- 
diol (513P) acetates on the C18 column by eluting with different 
ratio mixture of acetonitrile/H20 (15). Before the GC-C-IRMS 
analysis, an internal standard (5or acetate) 
with a known 813C-value is spiked in both fractions. Figure 2 
shows an example of GC-C-IRMS chromatograms ofm/z 44 for 
fractions F1 and F2. The chromatograms show symmetrical 
peaks for the compounds ofinterest, no tailing, and no evidence 
of co-eluting compounds. 
Each batch includes positive (QC-Pos) and negative (QC- 
Neg) quality controls and the measurements are performed 
for all metabolites in the linear ange of the IRMS. The purpose 
of the quality controls is to verify the reproducibility of the ex- 
traction procedure and the GC--C-IRMS measurements. The 
two incubation procedures given in the experimental part have 
been verified with the positive and negative quality controls to 
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Figure 2. Typical GC-C-IRMS m/z 44 mass chromatograms of fractions 
F1 (androsterone and etiocholanolone acetates)and F2 (5cr 
diol, 5[~-androstanediol, and 5[3-pregnanediol acetates) spiked with an 
internal standard (IS, 5mandrostan-3~-ol acetate). The square-topped 
peaks represent pulses of CO2 reference gas. 
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give comparable results. The within-assay precision was deter- 
mined by extracting six aliquots of QC-Pos and QC-Neg and in- 
jecting each once within the same day. For the determination 
of the between-assay precision, 20 aliquots of QC-Pos and QC- 
Neg were extracted by 4 different technicians over a period of 18 
months, and injected once each. For the within-assay precision 
the overall means and SD for etiocholanolone, androsterone, 
5[~-androstanediol, 5@-androstanediol, and5[3-pregnanediol in 
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the QC-neg were -24.6 (+0.1), -24.2 (+ 0.2), -23.9 (+ 0.1), 
-23.6 (+ 0.3), and -23.2 (+ 0.2) %0, respectively, whereas in 
the QC-pos, -27.9 (+ 0.3),-27.7 (• 0.2), -28.2 (• 0.2), -28.0 (+ 
0.2), and -23.2 (• 0.2) %owere obtained. For the between-assay 
precision, the overall means and SD for etiocholanolone, an- 
drosterone, 5[3-androstanediol, 5~-androstanediol, and 5~-preg- 
nanediol in the QC-neg were -24.4 (• 0.4), -24.0 (• 0.4), -24.3 
(• 0.3), -24.3 (• 0.4), and -23.7 (• 0.4) %0, respectively. For the 
QC-pos, means and SDs of-27.8 (_+ 0.4), -27.9 
-30 (+ 0.4),-27.8 (• 0.4),-28.4 (• 0.5), and -23.2 
~ (• 0.3) %owere obtained. These results indicate 
-28 ; that the SDs for each compound measured b -" with QC-neg and QC-pos are slightly higher 
in the case of the between-assay precision com- 
pared to the within-assay precision. Although 
this method allows for the 813C-value deter- 
mination of five steroids, the SDs are compa- 
80 10o rable to existing IRMS methods used fortwo T 
metabolites (12,16). 
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Figure 3. 813C-Values of androsterone, etiocholanolone, 50~-androstanediol, 5~-androstane- 
diol, and 5[~-pregnanediol together with the T/E ratio throughout he study period. Testosterone 
was administered at t = 0 and 13 h later (t = 13). The dotted line displays T/F ratio = 6. The hor- 
izontal lines a and b represent he 8UC-values for the mean and the mean - 3SD, respectively. 
Table I. Absolute 813C-Values of Androsterone, Etiocholanolone, 5ffA, 5~A, 
and 5~P of a Healthy, Caucasian, Male Population* 
Mean SD Range Median 
This This This this 
813C-value/%0 study ref 5 study Ref 5 study Ref 5 study 
Androsterone -23.2 - 1.23 - -21.2 to -25.3 - -23.2 
Etiocholanolone -24.4 - 0.83 - -22.1 to-25.8 - -24.6 
5cr -23,6 -17.5 1.00 3.53 -21.8 to-25.9 -10.5 to-24.6 -23.8 
5r -24.2 -20.0 1.15 2.75 -22.0to-26.3 -15.2 to-24.6 -24.3 
5~P -23,3 -21.0 1.17 1,65 -20.7to-25.6 -17.2 to-23.8 -23.2 
* (n = 40)9 Data obtained by Ueki and Okano (5) for an athlete population of males and females of various 
ethnicities (n > 350). 
~13C Values following oral testosterone 
administration 
The GC-C-IRMS and the T/E ratio results 
from the excretion study following oral ad- 
ministration of 40 mg testosterone unde- 
canoate initially and 13 h later is shown in 
Figure 3. Figure 3 also shows the mean and the 
mean-3SD 813C-values for androsterone, etio- 
cholanolone, 5~, 5~A, and 513P obtained after 
analysis of a reference population of healthy 
caucasian males (n = 40). Table I lists also the 
mean 813C-values, the median 813C-values, the 
SDs, the 813C range values of androsterone, 
etiocholanolone, 5r 5I~A, and 513P, together 
with the results obtained by Ueki and Okano 
(5) for 5~A, 5[3A, and 5[3P from a population of 
450 athletes who had participated to the XVII
Olympic Winter Games in Nagano (Japan). 
This population with a majority of Caucasian 
subjects may becompared to our data because 
a correction factor wasused to convert all mea- 
sured 813C-values of the acetylated compounds 
to give values forunderivatized steroids. A cor- 
rection factor was not applied for the popula- 
tion studies obtained by Shakelton et al. (2) 
and Aguilera et al. (16). As listed in Table I, 
only 5or 513A, and 513P may be compared with 
the data of Ueki and Okano (5). There are 
striking differences between th  ranges found 
in the two laboratories with mean differences 
of 6.1, 4.2, and 2.3%o for 5r 5[3A, and 5[~P, re- 
spectively. Moreover, our SDs are much lower 
to those obtained by Ueki and Okano (5). These 
results may be explained by a ifference of the 
analytical method or from the diet hetero- 
geneity of the population. Indeed, the diet of 
subjects from Europe is different from that of 
America and Japan and before the XVII 
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Olympic Winter Games in Nagano (Japan), the athletes did not 
eat the local diet for a sufficient time to have a measurable 
change of the steroids 813C-values in urine. Differences to eth- 
nicity may not explain the ranges of the 813C-values for 5~,  
513A, and 513P in a population (2,16). 
As reported in previous tudies (2,8), the r for 5bP 
should not be affected by the administration f testosterone 
since it has to be produced from cholesterol via several inter- 
mediates (Figure 1). A change of the 813C-value for 513P and for 
T metabolites could be expected if the individual modify dras- 
tically the diet during the study period. In the 41 urines col- 
lected during the excretion study, we determined a mean 
813C-value of -23.7%o with SD = • 0.4%0, range: -22.6 to 
-24.6%0 and median ---23.7%0 for 513P. The SD value is imilar 
to what obtained with the between-assay of QC-neg and QC-pos 
and shows that the 813C-values for 513P remain constant during 
the time course ofthe excretion. These findings reveal no di- 
etary modification during the excretion study and are in agree- 
ment with previous investigations (2,8). 
Interestingly, T/E ratio reach a maximum of 36 after both ad- 
ministrations and this value is higher than what has been re- 
ported (3) after an oral dose of 40 mg testosterone undecanoate 
for two caucasian i dividuals (T/E ratio = 22). These differ- 
ences may be rationalized as an interindividual variability in 
metabolism (17), such as genetic differences inthe cytochrome 
P450 system (7) and preferential biotransformation f the 
steroids. Differences in volume distribution and body weights 
may also explain these results. 
It is noteworthy that the T/E ratio increased rapidly following 
testosterone administration but returned below 6 after 10 and 
15 h for the first and second T administrations, respectively 
(Figure 3). Therefore only the urines collected uring this pe- 
riod would be considered as suspect and subject to further pro- 
cedures (6). Carbon isotope ratio measurements are also used 
for that purpose in detecting testosterone abuse. Similarly to 
the T/E ratio, the 51:~C-values of the four T metabolites de- 
crease rapidly after T administration with a difference ofabout 
5%o with respect to the endogenous reference 513P. These find- 
ings together with the fact that the values are out of the range 
as defined by the population mean - 3SD for all T metabolites 
would be strong indicators of testosterone abuse. Indeed, a dif- 
ference superior to 4%o with respect to the endogenous refer- 
ence 5~P is indicative of an exogenous T ingestion (8,16). This 
difference of 4%o is slightly higher to 3SD for all T metabolites 
of the reference population (Table I). 
The results how similar maximum 8t:3C-value variations for 
the T metabolites and concomitant changes of the T/E ratios 
after administration of the first and the second dose of T. 
Whereas androsterone, etiocholanolone, and 5c~-androstane- 
diol 8-values returned to the baseline 15 h after the second T ad- 
ministration, a decline in the 5c~-androstanediol 8-values co ld
be detected over 40 h. This finding may be related to different 
metabolic pathways with different kinetics from testosterone to 
T metabolites. For instance, it is known that urinary 5~-an- 
drostanediol arise from both epatic and peripheral metabolism 
whereas urinary 5[3-androstanediol is considered toarise only 
from hepatic metabolism (16). One should also consider the 
wash out period between the administration f the first and the 
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second ose. About 10.3 h after the second T dose, it may be ob- 
served on the T/E ratio profile that there is likely no residual ef- 
fect on this parameter from the first dose, whereas itmay not be 
excluded from the 5[3-androstanediol and ethiocholanolone 
813C-values. Other excretion studies on different subjects with 
multiple T ingestions are variable dose chedules would be 
needed to test this effect. 
It may be also emphasized that after ingestion of the second 
dose of T, there is a spot urine with a T/E ratio below 6 (T/E = 
5.6 at t = 23.3 h) that shows for androsterone, etiocholanolone, 
5r and 5[3-androstanediol a difference of 2.3, 
4.6, 1.8, and 4.9960, respectively, with the 813C-value ofthe en- 
dogenous reference 5[~P. For the subsequent spot urine at t = 26 
h, a T/E ratio of 2.7 was obtained with a ~13C-value superior to 
4%0 for 5[3-androstanediol. Fr m these results and other studies 
(3,12), it may be asked in routine procedure: 1.If the T/E ratio 
at 6 is still a valid cutoff and 2. What are the IRMS criteria to de- 
clare an exogenous T ingestion, that is, does all the measured T 
metabolite 813C-values ordoes only one have to be superior to 
4%0. Further excretion studies with multiple T ingestions 
should help in the future in deciding which riteria should be 
unilaterally adopted. 
In conclusion, our results uggest that measurements of 5[3- 
androstanediol 8-values allow the detection of a testosterone i -
gestion over a longer postadministration period than other T 
metabolites 813Covalues or than the usual T/E ratio approach. A 
difference of 4%o with respect to the endogenous reference 513P 
should be used as indicative of an exogenous T ingestion. As dis- 
cussed previously, the use of a reference population to report 
positive samples is questionable. 
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